Reduced stress changes profile of various lipid compounds

February 25, 2020

Reduced stress is linked to changes in the profile of plasma metabolites, a new study from the University of Eastern Finland shows. According to the researchers, the findings can shed light on the associations of psychological well-being with metabolism and the risk of disease. The study was published in Scientific Reports.

Psychological stress is known to be associated with obesity, low-grade inflammation and metabolic disorders, but the underlying mechanisms remain poorly understood. In the newly published study, the researchers used metabolite profiling to study whether improved psychological well-being is associated with measurable changes in metabolism. The study is a sub-study of Elixir, a large multi-centre lifestyle intervention study conducted by the Universities of Helsinki, Eastern Finland and Jyväskylä, and the Finnish Institute of Occupational Health.

The study participants were obese individuals with perceived psychological stress symptoms at the onset of the study. They were divided into two groups: one group to undergo a psychological lifestyle intervention (60 individuals) and a control group (64 individuals). Both groups managed to lose weight, but reduced stress and improved psychological well-being were reported by the intervention group in particular. Using metabolomics techniques, the researchers performed an extensive analysis of fasting metabolites in all study participants at beginning of the study and again nine months later, after the intervention had ended. Stress and psychological well-being were assessed by surveys and heart rate variability measurements.

Changes in the plasma levels of many phosphatidylcholines were associated with improved psychological well-being, and to some degree also with weight loss. Reduced stress and weight loss were associated with lower levels of certain lysophosphatidylcholines, and with higher levels of some plasmalogens. Obesity and the inflammatory marker interleukin-1 receptor antagonist, on the other hand, were inversely associated with these levels. The researchers also discovered previously unknown lipids that correlated with stress levels.

The observed associations of psychological well-being and weight loss with changes in the plasma lipid profile suggest that the lipids in question play a role in molecular-level mechanisms that interlink psychological and metabolic health.
-end-
For further information, please contact:

Research Director, Kati Hanhineva, University of Eastern Finland, tel. +358403552364, kati.hanhineva (a) uef.fi

Professor Marjukka Kolehmainen, University of Eastern Finland, tel. +358403553617, marjukka.kolehmainen (a) uef.fi

Research article:

Noerman, S., Klåvus, A., Järvelä-Reijonen, E., Karhunen, L., Auriola, S., Korpela, R., Lappalainen, R., Kujala, U.M., Puttonen, S., Kolehmainen, M. & Hanhineva, K. Plasma lipid profile associates with the improvement of psychological well-being in individuals with perceived stress symptoms. Sci Rep 10, 2143 (2020). https://doi.org/10.1038/s41598-020-59051-x

University of Eastern Finland

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.